KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Net Cash Flow (2016 - 2025)

HCA Healthcare (HCA) has disclosed Net Cash Flow for 16 consecutive years, with $43.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 104.53% to $43.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$902.0 million, a 190.29% decrease, with the full-year FY2025 number at -$902.0 million, down 190.29% from a year prior.
  • Net Cash Flow was $43.0 million for Q4 2025 at HCA Healthcare, down from $61.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $2.1 billion in Q3 2024 to a low of -$1.5 billion in Q2 2022.
  • A 5-year average of -$37.2 million and a median of $27.5 million in 2023 define the central range for Net Cash Flow.
  • Biggest YoY gain for Net Cash Flow was 5765.71% in 2024; the steepest drop was 2600.0% in 2024.
  • HCA Healthcare's Net Cash Flow stood at $423.0 million in 2021, then tumbled by 124.59% to -$104.0 million in 2022, then soared by 136.54% to $38.0 million in 2023, then crashed by 2600.0% to -$950.0 million in 2024, then skyrocketed by 104.53% to $43.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Net Cash Flow are $43.0 million (Q4 2025), $61.0 million (Q3 2025), and -$130.0 million (Q2 2025).